https://clinicaltrials.stanford.edu/trials/p/NCT03011372.html
Phase II INCB054828 in Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.
phase iimyeloidlymphoidneoplasms